Functional characterization of MLH1 missense variants unveils mechanisms of pathogenicity and clarifies role in cancer

PLoS One. 2022 Dec 1;17(12):e0278283. doi: 10.1371/journal.pone.0278283. eCollection 2022.

Abstract

Lynch syndrome is a heritable condition caused by a heterozygous germline inactivating mutation of the DNA mismatch repair (MMR) genes, most commonly the MLH1 gene. However, one third of the identified alterations are missense variants, for which the clinical significance is unclear in many cases. We have identified three MLH1 missense alterations (p.(Glu736Lys), p.(Pro640Thr) and p.(Leu73Pro)) in six individuals from large Tunisian families. For none of these alterations, a classification of pathogenicity was available, consequently diagnosis, predictive testing and targeted surveillance in affected families was impossible. We therefore performed functional laboratory testing using a system testing stability as well as catalytic activity that includes clinically validated reference variants. Both p.(Leu73Pro) and p.(Pro640Thr) were found to be non-functional due to severe defects in protein stability and catalytic activity. In contrast, p.(Glu736Lys) was comparable to the wildtype protein and therefore considered a neutral substitution. Analysis of residue conservation and of the structural roles of the substituted residues corroborated these findings. In conjunction with the available clinical data, two variants fulfil classification criteria for class 4 "likely pathogenic". The findings of this work clarify the mechanism of pathogenicity of two unclear MLH1 variants and enables predictive testing and targeted surveillance in members of carrier families worldwide.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Colorectal Neoplasms, Hereditary Nonpolyposis* / genetics
  • DNA Mismatch Repair
  • Germ-Line Mutation
  • Humans
  • MutL Protein Homolog 1 / genetics
  • Mutation, Missense*
  • Virulence

Substances

  • MLH1 protein, human
  • MutL Protein Homolog 1

Grants and funding

M.M. has received funding from the University of Monastir, Tunisia (http://www.um.rnu.tn/en/) and from the Higher Institute of Biotechnology of Monastir, Tunisia (http://www.um.rnu.tn/en/institutions/institutes/higher-institute-of-biotechnology-of-monastir/). The funders did not play any role in study design, data collection and analysis, decision to publish or preparation of manuscript.